Boxlight Corp 8-K Summary: June 8, 2020
Business Context and Reporting Period
Boxlight Corporation (Nasdaq: BOXL), a Nevada corporation, filed this Current Report on Form 8-K on June 8, 2020. The filing discloses the entry into a material definitive agreement regarding a public equity offering. The Company is classified as an emerging growth company.
Key Financial Metrics and Transaction Details
This filing details a capital raise rather than operational financial results. Key transaction metrics include:
- Shares Offered: 13,333,333 shares of Class A common stock.
- Offering Price: $0.75 per share.
- Gross Proceeds: Approximately $10.0 million (before discounts and expenses).
- Over-Allotment Option: Underwriters granted a 45-day option to purchase up to 2,000,000 additional shares.
- Underwriting Discount: 7% of the gross proceeds.
- Expense Reimbursement: Up to $85,000 for underwriting expenses.
Note: The filing text does not provide current revenue, profit, cash flow, margins, debt, or liquidity figures. These metrics are not disclosed in this specific 8-K report.
Material Changes
The primary material change is the execution of an underwriting agreement with Maxim Group, LLC (sole bookrunner) and National Securities Corporation (co-manager). This agreement facilitates the public offering of common stock, representing a significant change in the Company's capital structure pending the closing of the transaction.
Outlook, Risks, and Management Commentary
The offering is expected to close on or about June 11, 2020, subject to customary closing conditions. The transaction is conducted pursuant to a previously effective Form S-1 registration statement. The filing references a press release (Exhibit 99.1) for further management commentary but does not contain specific forward-looking guidance, risk factors, or contingency details within the text of this report itself.
Investor Verification Checklist
- Verify the final closing date of the offering (expected June 11, 2020).
- Confirm whether the underwriters exercised the 2,000,000 share over-allotment option.
- Review the full Underwriting Agreement (Exhibit 10.1) for specific covenants and conditions.
- Check subsequent filings for the actual net proceeds received after deducting the 7% discount and expenses.
- Examine the referenced Form S-1 (File No. 333-238634) for detailed risk factors and use of proceeds.